Literature DB >> 31773028

Research Facility for Radiobiological Studies at the University Proton Therapy Dresden.

Elke Beyreuther1,2, Michael Baumann1,3,4,5, Wolfgang Enghardt1,2,4,5, Stephan Helmbrecht1,2, Leonhard Karsch1,2, Mechthild Krause1,2,4,6,7, Jörg Pawelke1,2, Lena Schreiner1, Michael Schürer1,7, Cläre von Neubeck1,5, Armin Lühr1,2,5.   

Abstract

PURPOSE: In order to take full advantage of proton radiotherapy, the biological effect of protons in normal and tumor tissue should be investigated and understood in detail. The ongoing discussion on variable relative biological effectiveness along the proton depth dose distribution (eg, Paganetti 2015), and also the administration of concomitant treatments, demands dedicated in vitro trials that prepare the translation into the clinics. Therefore, a setup for radiobiological studies and the corresponding dosimetry should be established that enables in vitro experiments at a horizontal proton beam and a clinical 6 MV photon linear accelerator (Linac) as reference.
METHODS: The experimental proton beam at the University Proton Therapy Dresden is characterized by high beam availability and reliability throughout the day in parallel to patient treatment. For cell irradiation, a homogeneous 10 × 10 cm2 proton field with an optional spread-out Bragg-peak can be formed. A water-filled phantom was installed that allows for precise positioning of different sample geometries along the proton path.
RESULTS: Depth-dose profiles within the phantom and dose homogeneity over different cell samples were characterized for the proton beam and the photon reference source. A daily quality assurance protocol was implemented that provides absolute dose information required for significant and reproducible in vitro experiments. Cell survival test experiments were performed to demonstrate the feasibility of such experiments.
CONCLUSION: In the experimental room of the University Proton Therapy Dresden, clinically relevant conditions for proton in vitro experiments have been realized. The established cell phantom and dosimetry facilitate irradiation in an aqueous environment and are transferable to other proton, photon and ion beam facilities. Precise positioning and easy exchange of cell samples, monitor unit-based dose delivery, and high beam availability allow for systematic in vitro experiments. The close vicinity to the radiotherapy and radiobiology departments provides access to clinical linacs and the interdisciplinary basis for further translational steps. ©Copyright 2018 International Journal of Particle Therapy.

Entities:  

Keywords:  University Proton Therapy Dresden; proton RBE; proton in vitro setup; proton radiobiology

Year:  2018        PMID: 31773028      PMCID: PMC6871594          DOI: 10.14338/IJPT-18-00008.1

Source DB:  PubMed          Journal:  Int J Part Ther        ISSN: 2331-5180


  27 in total

Review 1.  Relative biological effectiveness (RBE) values for proton beam therapy. Variations as a function of biological endpoint, dose, and linear energy transfer.

Authors:  Harald Paganetti
Journal:  Phys Med Biol       Date:  2014-10-31       Impact factor: 3.609

Review 2.  Radiation oncology in the era of precision medicine.

Authors:  Michael Baumann; Mechthild Krause; Jens Overgaard; Jürgen Debus; Søren M Bentzen; Juliane Daartz; Christian Richter; Daniel Zips; Thomas Bortfeld
Journal:  Nat Rev Cancer       Date:  2016-03-18       Impact factor: 60.716

Review 3.  Overview of research and therapy facilities for radiobiological experimental work in particle therapy. Report from the European Particle Therapy Network radiobiology group.

Authors:  Manjit Dosanjh; Bleddyn Jones; Jörg Pawelke; Martin Pruschy; Brita Singers Sørensen
Journal:  Radiother Oncol       Date:  2018-04-24       Impact factor: 6.280

4.  Incidence of CNS Injury for a Cohort of 111 Patients Treated With Proton Therapy for Medulloblastoma: LET and RBE Associations for Areas of Injury.

Authors:  Drosoula Giantsoudi; Roshan V Sethi; Beow Y Yeap; Bree R Eaton; David H Ebb; Paul A Caruso; Otto Rapalino; Yen-Lin E Chen; Judith A Adams; Torunn I Yock; Nancy J Tarbell; Harald Paganetti; Shannon M MacDonald
Journal:  Int J Radiat Oncol Biol Phys       Date:  2015-09-24       Impact factor: 7.038

5.  Clinical evidence of variable proton biological effectiveness in pediatric patients treated for ependymoma.

Authors:  Christopher R Peeler; Dragan Mirkovic; Uwe Titt; Pierre Blanchard; Jillian R Gunther; Anita Mahajan; Radhe Mohan; David R Grosshans
Journal:  Radiother Oncol       Date:  2016-11-16       Impact factor: 6.280

6.  Methodologies in the modeling of combined chemo-radiation treatments.

Authors:  C Grassberger; H Paganetti
Journal:  Phys Med Biol       Date:  2016-10-19       Impact factor: 3.609

7.  HPV16 DNA status is a strong prognosticator of loco-regional control after postoperative radiochemotherapy of locally advanced oropharyngeal carcinoma: results from a multicentre explorative study of the German Cancer Consortium Radiation Oncology Group (DKTK-ROG).

Authors:  Fabian Lohaus; Annett Linge; Inge Tinhofer; Volker Budach; Eleni Gkika; Martin Stuschke; Panagiotis Balermpas; Claus Rödel; Melanie Avlar; Anca-Ligia Grosu; Amir Abdollahi; Jürgen Debus; Christine Bayer; Claus Belka; Steffi Pigorsch; Stephanie E Combs; David Mönnich; Daniel Zips; Cläre von Neubeck; Gustavo B Baretton; Steffen Löck; Howard D Thames; Mechthild Krause; Michael Baumann
Journal:  Radiother Oncol       Date:  2014-12-02       Impact factor: 6.280

8.  Differential DNA repair pathway choice in cancer cells after proton- and photon-irradiation.

Authors:  Andrea O Fontana; Marc A Augsburger; Nicole Grosse; Matthias Guckenberger; Anthony J Lomax; Alessandro A Sartori; Martin N Pruschy
Journal:  Radiother Oncol       Date:  2015-08-25       Impact factor: 6.280

Review 9.  Relative biological effectiveness in proton beam therapy - Current knowledge and future challenges.

Authors:  Armin Lühr; Cläre von Neubeck; Mechthild Krause; Esther G C Troost
Journal:  Clin Transl Radiat Oncol       Date:  2018-02-01

10.  Variations in the Processing of DNA Double-Strand Breaks Along 60-MeV Therapeutic Proton Beams.

Authors:  Pankaj Chaudhary; Thomas I Marshall; Frederick J Currell; Andrzej Kacperek; Giuseppe Schettino; Kevin M Prise
Journal:  Int J Radiat Oncol Biol Phys       Date:  2015-07-29       Impact factor: 7.038

View more
  3 in total

1.  Combined Systemic Drug Treatment with Proton Therapy: Investigations on Patient-Derived Organoids.

Authors:  Max Naumann; Tabea Czempiel; Anna Jana Lößner; Kristin Pape; Elke Beyreuther; Steffen Löck; Stephan Drukewitz; Alexander Hennig; Cläre von Neubeck; Barbara Klink; Mechthild Krause; Doreen William; Daniel E Stange; Rebecca Bütof; Antje Dietrich
Journal:  Cancers (Basel)       Date:  2022-08-03       Impact factor: 6.575

2.  Comparative Proton and Photon Irradiation Combined with Pharmacological Inhibitors in 3D Pancreatic Cancer Cultures.

Authors:  Josephine Görte; Elke Beyreuther; Erik H J Danen; Nils Cordes
Journal:  Cancers (Basel)       Date:  2020-10-31       Impact factor: 6.639

3.  Comparative Therapeutic Exploitability of Acute Adaptation Mechanisms to Photon and Proton Irradiation in 3D Head and Neck Squamous Cell Carcinoma Cell Cultures.

Authors:  Annina Meerz; Sara Sofia Deville; Johannes Müller; Nils Cordes
Journal:  Cancers (Basel)       Date:  2021-03-10       Impact factor: 6.639

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.